Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Clin Imaging ; 90: 32-38, 2022 Oct.
Article in English | MEDLINE | ID: mdl-35914341

ABSTRACT

Acute abdominal pain is a common cause of ED visits and often requires imaging to identify a specific diagnosis. Prompt and appropriate imaging plays a crucial role in patient management and leads to improved patient outcomes, decreased hospital stay, and improved ED workflow. There are many cases of abdominal pain in the ED with delayed diagnosis and management secondary to a combination of institutional policies and knowledge deficits in current imaging guidelines. Inappropriate use of abdominal radiographs, use of oral contrast for CT abdomen and pelvis, and concern for iodinated contrast-induced acute kidney injury are three of the more commonly encountered roadblocks to prompt imaging diagnosis of abdominal pain. The purpose of this review is to discuss why these potential causes of delayed diagnosis occur and how radiologists can help improve both imaging and ED workflow by utilizing the most up-to-date imaging guidelines such the American College of Radiology (ACR) Appropriateness Criteria and ACR Manual on Contrast Media to assist clinicians working in the emergency setting.


Subject(s)
Abdominal Pain , Emergency Service, Hospital , Abdominal Pain/diagnostic imaging , Abdominal Pain/etiology , Contrast Media/adverse effects , Humans , Radiography, Abdominal/methods , Tomography, X-Ray Computed/methods
2.
Acad Radiol ; 29(12): 1869-1884, 2022 12.
Article in English | MEDLINE | ID: mdl-35382975

ABSTRACT

Cancer immunotherapies are drugs that modulate the body's own immune system as an anticancer strategy. Checkpoint inhibitor immunotherapies interfere with cell surface binding proteins that function to promote self-recognition and tolerance, ultimately leading to upregulation of the immune response. Given the striking success of these agents in early trials in melanoma and lung cancer, they have now been studied in many types of cancer and have become a pillar of anticancer therapy for many tumor types. However, abundant upregulation results in a new class of side effects, known as immune-related adverse events (IRAEs). It is critical for the practicing radiologist to be able to recognize these events to best contribute to care for patients on checkpoint inhibitor immunotherapy. Here, we provide a comprehensive system-based review of immune-related adverse events and associated imaging findings. Further, we detail the best imaging modalities for each as well as describe problem solving modalities. Given that IRAEs can be subclinical before becoming clinically apparent, radiologists may be the first provider to recognize them, providing an opportunity for early treatment. Awareness of IRAEs and how to best image them will prepare radiologists to make a meaningful contribution to patient care as part of the clinical team.


Subject(s)
Drug-Related Side Effects and Adverse Reactions , Lung Neoplasms , Melanoma , Neoplasms , Humans , Immunotherapy/adverse effects , Immunotherapy/methods , Neoplasms/therapy , Melanoma/drug therapy , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/drug therapy , Multimodal Imaging
3.
Clin Imaging ; 67: 108-112, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32559680

ABSTRACT

Patients suspected of having an acute aortic syndrome in the ED typically undergo CT of the chest/abdomen/pelvis. However, the overwhelming majority of these exams are negative. With the help of clinical decision support, we implemented a new radiologist monitored 'aortic dissection screening protocol' that forgoes routine abdominopelvic imaging in order to reduce radiation dose without compromising diagnostic accuracy. The purpose of the present study is to assess the performance of this protocol. A retrospective analysis was performed to study the effect of the dissection screening protocol on the diagnostic yield, radiation and contrast dose on a total of 835 ED patients who underwent CT scans for suspected aortic dissection over a 48-week study period immediately before and after implementation of the protocol. 3.4% (28/835) of examinations were positive for an acute aortic syndrome over the 48-week study period with no difference in positivity before and after implementation of the 'aortic dissection screening' protocol, 3.0% vs. 3.7%, respectively (p = 0.57). There was a 14.6% reduction in median radiation dose and a 16% decrease in contrast volume utilization for the total ED population who underwent CT for aortic dissection using any protocol in the period after implementation of the 'aortic dissection screening' protocol. Aortic dissection CT in the ED is negative in the overwhelming majority of cases. A monitored 'aortic dissection screening' protocol that initially images the chest only significantly reduced contrast and radiation dose without reducing diagnostic accuracy for ED patients who underwent CT for aortic dissection.


Subject(s)
Aortic Dissection/diagnostic imaging , Computed Tomography Angiography , Aged , Antineoplastic Combined Chemotherapy Protocols , Aortography , Contrast Media , Cytarabine , Decision Support Systems, Clinical , Female , Humans , Male , Middle Aged , Radiation Dosage , Radiation Exposure , Retrospective Studies , Thioguanine , Tomography, X-Ray Computed/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...